---
name: Aurigene Pharmaceutical Services Limited
slug: aurigeneservices
site: both
website_domain: aurigeneservices.com
summary: Integrated CRO-CDMO with 25+ years of discovery and development expertise across small and large molecules, operating 16 US FDA-inspected cGMP facilities across three manufacturing countries. Headquartered in India.
tagline: Integrated CRO-CDMO with 25+ years of discovery and manufacturing expertise across small and large molecules.
founded_year: 
employee_count_band: 1001-5000
employee_count_label: 1,001–5,000
parent_name: 
parent_slug: 
hq_country: IN
tier2_domain_verified: false
updated_at: 2026-06-16T07:05:18.626Z
services_count: 6
modalities_count: 3
indications_count: 0
locations_count: 3
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Aurigene Pharmaceutical Services Limited

Integrated CRO-CDMO with 25+ years of discovery and manufacturing expertise across small and large molecules.

Listed on cdmo.directory.

## Summary

Integrated CRO-CDMO with 25+ years of discovery and development expertise across small and large molecules, operating 16 US FDA-inspected cGMP facilities across three manufacturing countries. Headquartered in India.

## At a glance

- Employees (est.): 1,001–5,000
- HQ country: IN

## Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- Protein Engineering

## Modalities

- Small Molecule
- Biologics (Other)
- Peptide

## Locations

- Manufacturing - India, India
- Manufacturing - UK, United Kingdom
- Manufacturing - Mexico, Mexico

## Certifications

- FDA; Identifier: 16 US FDA-inspected cGMP facilities; Source: https://aurigeneservices.com/

## Long description

Aurigene Pharmaceutical Services Limited is a contract research, development, and manufacturing organization (CDMO) offering end-to-end solutions from discovery through commercialization. The company operates as an integrated CRO-CDMO, serving global innovative pharma and biotech companies.

### Discovery Services
With over 25 years of operations, Aurigene provides small molecule discovery services spanning chemistry, biology, and integrated services across the drug discovery lifecycle—from target identification through IND filing. The organization maintains long-term partnerships with two of the top five pharmaceutical companies and operates flexibly in FTE (full-time equivalent) and/or FFS (fee-for-service) modes, both integrated and standalone.

### Manufacturing & Compliance
The company operates 16 US FDA-inspected cGMP facilities across three manufacturing countries (UK, Mexico, India). To date, Aurigene has delivered 600+ lifetime discovery and CDMO projects globally, with 20 NCEs and 6 biologics commercialized.

### Sustainability & Operations
Beyond science, operations are rooted in compliance, information security, quality, and sustainability. Aurigene became water-positive in 2023 and has committed to 100% renewable power by 2030, carbon neutrality in direct operations (Scope 1 & 2) by 2030, and a 12.5% reduction in indirect supply chain emissions (Scope 3) by 2030.

_Profile last updated: 2026-06-16T07:05:18.626Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.